Our data not only established RBP4 as a direct linkage between obesity and ovarian cancer, but also suggested RBP4 was a possible target for cancer treatment, especially in those associated with obesities. The gene discussed is RBP4; the disease is obesity due to melanocortin 4 receptor deficiency.